Indaptus Therapeutics, Inc. (INDP)
NASDAQ: INDP · Real-Time Price · USD
0.938
+0.048 (5.39%)
Dec 20, 2024, 4:00 PM EST - Market closed
Indaptus Therapeutics Employees
Indaptus Therapeutics had 7 employees as of December 31, 2023. The number of employees increased by 1 or 16.67% compared to the previous year.
Employees
7
Change (1Y)
1
Growth (1Y)
16.67%
Revenue / Employee
n/a
Profits / Employee
-$2,127,680
Market Cap
9.56M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 7 | 1 | 16.67% |
Dec 31, 2022 | 6 | 1 | 20.00% |
Dec 31, 2021 | 5 | 3 | 150.00% |
Dec 31, 2020 | 2 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Evogene | 142 |
Applied DNA Sciences | 55 |
Viracta Therapeutics | 40 |
Cellectar Biosciences | 20 |
Purple Biotech | 20 |
Kiora Pharmaceuticals | 12 |
SeaStar Medical Holding | 12 |
COSCIENS Biopharma | 12 |
INDP News
- 4 weeks ago - Indaptus Therapeutics, Inc. Announces $2.135 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewsWire
- 5 weeks ago - Indaptus Therapeutics' Pioneering Research on Novel Immunotherapy Approach Published in Peer-Reviewed Frontiers in Immunology - GlobeNewsWire
- 6 weeks ago - Indaptus Therapeutics Presents Encouraging Interim Safety Data from Phase 1 Clinical Trial of Decoy20 at the Society for Immunotherapy of Cancer (SITC) 2024 Annual Meeting - GlobeNewsWire
- 2 months ago - Indaptus Therapeutics to Present at Two Upcoming Investor Conferences - GlobeNewsWire
- 8 months ago - Indaptus Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update - GlobeNewsWire
- 9 months ago - Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting - GlobeNewsWire
- 9 months ago - Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting - GlobeNewsWire
- 10 months ago - Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update - GlobeNewsWire